Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

WAKE-UP provides new treatment option for stroke patients | International study led by UKE

17.05.2018

In an international study, scientists of the University Medical Center Hamburg-Eppendorf (UKE) have discovered a new therapeutic option for a large group of stroke patients. The main results of the European WAKE-UP trial were presented today at the European Stroke Organisation Conference (ESOC) in Gothenburg, Sweden. At the same time, the trial results were published in the New England Journal of Medicine. These results will enable effective treatment of a large group of stroke patients currently ex-cluded from intravenous thrombolysis.

Up to 20 per cent of stroke patients wake up in the morning with stroke symptoms. This means that the time when their stroke started is unknown and so they are not routinely eligible for clot-busting treatment (thrombolysis) with drugs such as alteplase, which is only approved to be used within 4.5 hours after the start of stroke symptoms.


| Prof. Dr. Götz Thomalla (r.)

University Medical Center Hamburg-Eppendorf (UKE)


Prof. Dr. Götz Thomalla and Prof. Dr. Christian Gerloff from the Department of Neurology at the University Medical Center Hamburg-Eppendorf (UKE)

University Medical Center Hamburg-Eppendorf (UKE)

Every year about two million patients have a stroke in the EU, including approximately 400.000 patients with ‘wake-up-stroke’ or who otherwise have un-known time of symptom onset.

Now, the WAKE-UP study has revealed for the first time that selecting patients for treatment based on what is shown in their MRI brain images can be used to decide if they get thrombolysis. By com-paring different images from the MRI examination, clinicians can now deduce when a stroke is likely to have started, and whether a patient is likely to benefit from thrombolysis.

WAKE-UP trial was conducted at 70 centers in eight European countries, and was led by Prof. Götz Thomalla and Prof. Christian Gerloff from the Department of Neurology at the University Medical Center Hamburg-Eppendorf. The study received funding from the 7th framework programme of the European Union.

“The positive result of WAKE-UP is a milestone”

Patients were studied by MRI with the combination of two different MRI sequences. The first scan, called diffusion weighted imaging (DWI), shows early changes in the brain after stroke whereas changes take several hours to become obvious in the second type of scan, called FLAIR (fluid-attenuated inversion recovery). If a stroke lesion was apparent on DWI but not yet on FLAIR images, then a patient was highly likely to still be within 4.5 hours of symptom onset and thus a candidate to benefit from thrombolysis.

In WAKE-UP, treatment with alteplase gave a significantly higher rate of favorable outcomes. 53.3 per cent of patients treated with alteplase achieved a favorable outcome, as compared to 41.8 per cent in the placebo group, representing an absolute increase of 11.5 per cent.

“The positive result of WAKE-UP is a milestone towards further improvement of the treatment of acute stroke, as the trial opens the window for treating many patients that have been excluded from thrombolysis until now”, says Prof. Thomalla. “Treatment based on MRI-selection without knowing the time of symptom onset represents a paradigm change for acute stroke thrombolysis.“

Researchers hope that the results of WAKE-UP will have an immediate impact on clinical practice and guidelines of stroke treatment and that MRI-based thrombolysis will become the standard of care. Based on the trial results, many thousands of stroke patients will be saved from a future of stroke-related disability.

Literature

Thomalla G., Gerloff C. et al., MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset, New England Journal of Medicine 2018. DOI: 10.1056/NEJMoa1804355

More information: www.wakeup-stroke.eu

Please follow this link for photographs (Prof. Thomalla/Prof. Gerloff): www.uke.de/pressebilder

Contact

Due to the fact that the scientists are at the European Stroke Organisation Conference in Gothen-burg, Sweden, we kindly ask you to get in touch by e-mail.

Prof. Dr. Götz Thomalla
Department of Neurology
University Medical Center Hamburg-Eppendorf (UKE)
Martinistrasse 52
D-20246 Hamburg
thomalla@uke.de

Prof. Dr. Christian Gerloff
Department of Neurology
University Medical Center Hamburg-Eppendorf (UKE)
Martinistrasse 52
D-20246 Hamburg
gerloff@uke.de

Saskia Lemm | idw - Informationsdienst Wissenschaft

Further reports about: MRI Neurology STROKE Thrombolysis UKE brain images stroke symptoms

More articles from Studies and Analyses:

nachricht Novel study underscores microbial individuality
13.12.2019 | Bigelow Laboratory for Ocean Sciences

nachricht TU Dresden biologists examine sperm quality on the basis of their metabolism
29.11.2019 | Technische Universität Dresden

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Miniature double glazing: Material developed which is heat-insulating and heat-conducting at the same time

Styrofoam or copper - both materials have very different properties with regard to their ability to conduct heat. Scientists at the Max Planck Institute for Polymer Research (MPI-P) in Mainz and the University of Bayreuth have now jointly developed and characterized a novel, extremely thin and transparent material that has different thermal conduction properties depending on the direction. While it can conduct heat extremely well in one direction, it shows good thermal insulation in the other direction.

Thermal insulation and thermal conduction play a crucial role in our everyday lives - from computer processors, where it is important to dissipate heat as...

Im Focus: Fraunhofer IAF establishes an application laboratory for quantum sensors

In order to advance the transfer of research developments from the field of quantum sensor technology into industrial applications, an application laboratory is being established at Fraunhofer IAF. This will enable interested companies and especially regional SMEs and start-ups to evaluate the innovation potential of quantum sensors for their specific requirements. Both the state of Baden-Württemberg and the Fraunhofer-Gesellschaft are supporting the four-year project with one million euros each.

The application laboratory is being set up as part of the Fraunhofer lighthouse project »QMag«, short for quantum magnetometry. In this project, researchers...

Im Focus: How Cells Assemble Their Skeleton

Researchers study the formation of microtubules

Microtubules, filamentous structures within the cell, are required for many important processes, including cell division and intracellular transport. A...

Im Focus: World Premiere in Zurich: Machine keeps human livers alive for one week outside of the body

Researchers from the University Hospital Zurich, ETH Zurich, Wyss Zurich and the University of Zurich have developed a machine that repairs injured human livers and keep them alive outside the body for one week. This breakthrough may increase the number of available organs for transplantation saving many lives of patients with severe liver diseases or cancer.

Until now, livers could be stored safely outside the body for only a few hours. With the novel perfusion technology, livers - and even injured livers - can now...

Im Focus: SuperTIGER on its second prowl -- 130,000 feet above Antarctica

A balloon-borne scientific instrument designed to study the origin of cosmic rays is taking its second turn high above the continent of Antarctica three and a half weeks after its launch.

SuperTIGER (Super Trans-Iron Galactic Element Recorder) is designed to measure the rare, heavy elements in cosmic rays that hold clues about their origins...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

11th Advanced Battery Power Conference, March 24-25, 2020 in Münster/Germany

16.01.2020 | Event News

Laser Colloquium Hydrogen LKH2: fast and reliable fuel cell manufacturing

15.01.2020 | Event News

„Advanced Battery Power“- Conference, Contributions are welcome!

07.01.2020 | Event News

 
Latest News

A new 'cool' blue

17.01.2020 | Life Sciences

EU-project SONAR: Better batteries for electricity from renewable energy sources

17.01.2020 | Power and Electrical Engineering

Neuromuscular organoid: It’s contracting!

17.01.2020 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>